Stay updated on Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision history shows the addition of Revision v3.3.2 and the removal of Revision v3.2.0; no study data, status, or other page content changes were made. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:41:27.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    - The government funding status notice was removed from the page, and this does not affect the trial data or core study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:17:01.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    New versions are added to the Record History with updated statuses/locations; core trial details remain unchanged.
    Difference
    0.1%
    Check dated 2025-11-03T21:26:16.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Added a prominent operating-status notice and a v3.2.0 version tag, replacing the prior v3.1.0 revision.
    Difference
    9%
    Check dated 2025-10-06T06:58:36.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.2%
    Check dated 2025-09-29T03:35:08.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    New date and study status were added; an older date was removed, indicating an update to current content.
    Difference
    0.9%
    Check dated 2025-09-22T00:20:36.000Z thumbnail image

Stay in the know with updates to Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial page.